Savara To Present New Data at the American Thoracic Society (ATS) 2026 International Conference
LANGHORNE, Pa.--(BUSINESS WIRE)--Apr 14, 2026-- Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the acceptance of one oral presentation and two poster presentations at the ATS …